These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 1608367)
1. Surfactant replacement therapy: issues related to currently available preparations. Bose G Neonatal Netw; 1992 Jun; 11(4):vii-xii. PubMed ID: 1608367 [No Abstract] [Full Text] [Related]
6. Costs and outcomes associated with colfosceril versus beractant for the treatment of neonatal respiratory distress syndrome. Wyble L; Santeiro ML Ann Pharmacother; 1997 Jun; 31(6):787-8. PubMed ID: 9184726 [No Abstract] [Full Text] [Related]
7. Criteria for use of colfosceril (Exosurf) in neonates. Bhatt-Mehta V; Schumacher RE Clin Pharm; 1992 Apr; 11(4):355-7. PubMed ID: 1563234 [No Abstract] [Full Text] [Related]
8. Surfactant therapy for hyaline membrane disease: the Chandigarh experience. Narang A; Kumar P; Dutta S; Kumar R Indian Pediatr; 2001 Jun; 38(6):640-6. PubMed ID: 11418729 [No Abstract] [Full Text] [Related]
11. Cerebral blood flow velocity after surfactant instillation in preterm infants. van de Bor M; Ma EJ; Walther FJ J Pediatr; 1991 Feb; 118(2):285-7. PubMed ID: 1993962 [No Abstract] [Full Text] [Related]
12. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome]. Bratlid D; Farstad T Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279 [TBL] [Abstract][Full Text] [Related]
13. Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study. Sehgal SS; Ewing CK; Richards T; Taeusch HW J Natl Med Assoc; 1994 Jan; 86(1):46-52. PubMed ID: 8151722 [TBL] [Abstract][Full Text] [Related]
14. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. The American Exosurf Neonatal Study Group I, and the Canadian Exosurf Neonatal Study Group. Long W; Corbet A; Cotton R; Courtney S; McGuiness G; Walter D; Watts J; Smyth J; Bard H; Chernick V N Engl J Med; 1991 Dec; 325(24):1696-703. PubMed ID: 1944470 [TBL] [Abstract][Full Text] [Related]
15. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group. Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614 [TBL] [Abstract][Full Text] [Related]
16. Impact of surfactant replacement therapy on the nursery. Nightengale B Neonatal Netw; 1992 Jun; 11(4):xiii-xvi. PubMed ID: 1608368 [No Abstract] [Full Text] [Related]